Nephrology DigestCOVID-19Blockade of SARS-CoV-2 infection by recombinant soluble ACE2
COVID-19
Under a Creative Commons license
open access
Keywords
ACE2
COVID-19
renin-angiotensin system
viral infection
Cited by (0)
Refers to: Monteil V, Kwon H, Prado P, et al. Inhibition of SARS-CoV-2 infections in engineered human tissues using clinical-grade soluble human ACE2 [e-pub ahead of print]. Cell. https://doi.org/10.1016/j.cell.2020.04.004. Accessed April 9, 2020.
© 2020 The Authors. Published by Elsevier Inc. on behalf of the International Society of Nephrology.